VI. Bibliography

  1. Allende S, Carvell HC. Mexico: status of cancer pain and palliative care. J Pain Symptom Manage. 1996;12:121-123.
  2. Zhang H, Gu W, Joranson DE, Cleeland CS. Peoples Republic of China: status of cancer pain and palliative care. J Pain Symptom Manage. 1996;12(2):124-126.
  3. Joranson DE. Availability of opioids for cancer pain: recent trends, assessment of system barriers, new World Health Organization guidelines, and the risk of diversion. J Pain Symptom Manage. 1993;8(6):353-360.
  4. Joranson DE, Gilson AM, Ryan KM, Maurer MA, Nelson JM. Achieving balance in state pain policy: a guide to evaluation. Madison, Wisconsin: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care; 1999.
  5. Joranson DE, Gilson AM. Controlled substances, medical practice, and the law. In: Schwartz HI, ed. Psychiatric practice under fire: the influence of government, the media, and special interests on somatic therapies. Washington DC: American Psychiatric Press, Inc.;1994:173-194.
  6. World Health Organization. Achieving balance in national drug control policy: guidelines for self-assessment. Geneva, Switzerland: World Health Organization, in press.
  7. Joranson DE. Guidelines: how to obtain morphine for cancer pain relief and palliative care in India. Indian J Palliat Care. 1998;4:5-12.
  8. Joranson DE. A proposal to simplify India Narcotic Drugs and Psychotropic Substances Act (NDPS) to improve cancer patient access to pain medications. Indian J Palliat Care. 1998;4:12-16.
  9. Sikora, S. Correspondence to Dr. M.K. Rajagopal regarding the WHO Demonstration Project Status.
  10. Janjan NA, Martin CG, Payne R, Dahl JL, Weissman DE, Hill CS. Durability of education in cancer pain management principles with role model program. Cancer. 1996:77:996-1001.
  11. Weissman DE, Dahl JL. Update on the cancer pain role model education program. J Pain Symptom Manage. 1995; 10:292-297.
  12. Weissman DE, Dahl JL, Beasley JW. The cancer pain role model program of the Wisconsin Cancer Pain Initiative. J Pain Symptom Manage. 1993;8:29-35.
  13. Weissman DE, Griffie J, Gordon DB, Dahl JL. A role model program to promote institutional changes for management of acute and cancer pain. J Pain Symptom Manage. 1997;14:274-279.
  14. Joranson DE. Availability of opiates and psychotropic drugs for medical purposes. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Prepared for the International Narcotics Control Board/Interamerican Commission on Drug Abuse Workshop; San Juan, Puerto Rico; 2 December 1997 (Monograph).
  15. Joranson DE, Gilson AM, Monterroso M, Nelson JM, De Lima, L. Opioid analgesics in Latin America: trends, legal requirements, recommendations. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Poster presented at for the 5th Latin American Congress of Palliative care; Concepción, Chile; 8-11 March 1998.
  16. Colleau SM. Panorama del cuidado paliativo en Latinoamérica: datos de 1994, 1996 y 1998. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Poster presented at the 5th Latin American Congress of Palliative Care; Concepción, Chile; 8-11 March 1998.
  17. Joranson DE, Gilson AM, Monterroso M, Nelson JM. Opioid analgesics in Latin America: trends, legal requirements, recommendations. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Prepared for the 5th Latin American Congress of Palliative care; Concepción, Chile; 8-11 March 1998 (Monograph).
  18. De Lima L, Bruera E, Joranson DE, et al. Opioid availability in Latin America: the Santo Domingo report-progress since the Declaration of Florianopolis. J Pain Symptom Manage. 1997;13:213-219.
  19. Joranson DE. Papel del gobierno: asegurar la disponibilidad de opiáceos y prevención de abuso. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Presented at the 3rd International Course: Palliative Care of the Oncological Patient; Mexico, D.F.; 1-3 October 1997.
  20. Joranson DE, De Lima L. Preliminary analysis of the Mexican legislation in relation to the international principles of opioid availability. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. March 1996 (Monograph).
  21. Joranson DE, Gilson AM, Nelson JM, Colleau SM. Disponibilidad de opioides para el alivio del dolor en cáncer: puntos relevantes en América Latina. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Prepared for the 6th International Course on Pain Control of the Fundación Dolor; Buenos Aires, Argentina; 14-17 May 1999 (Monograph).
  22. Colleau SM. Educación en el alivio del dolor y el cuidado paliativo: una guía de los recursos. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Prepared for the 6th International Course on Pain Control of the Fundación Dolor; Buenos Aires, Argentina; 14-17 May 1999 (Monograph).
  23. Joranson DE, De Lima L. Preliminary analysis of the Colombian legislation in relation to the international principles of opioid availability. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. March 1996 (Monograph).
  24. De Lima L. El empleo de analgesicos opiáceos para el alivio del dolor por cancer. Revista Panamericana de la Salud/Pan Am J Public Health. 1997;2(2):142-145.
  25. Joranson DE, Gilson AM. Opioid availability: diagnosis and treatment of regulatory barriers. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Presented at the European Association for Palliative Care Regional Meeting; Cyprus; 1997 (Monograph).
  26. Joranson DE. Reflections on addiction to morphine. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Presented at the 5th Congress of the European Association for Palliative Care; London, England; 11 September 1997.
  27. International Narcotics Control Board. Report of the International Narcotics Control Board for 1995: availability of opiates for medical needs. Vienna, Austria: International Narcotics Control Board; 1996.
  28. Joranson DE, Gilson AM, Ryan KM. Survey on opioid availability in Eastern Europe. Madison, Wisconsin: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care; 1999.
  29. Selva C. International control of opioids for medical use. Eur J Palliat Care. 1997;4(6):194-198.
  30. World Health Organization. Cancer pain relief: with a guide to opioid availability. Second ed. Geneva, Switzerland: World Health Organization; 1996.
  31. Joranson DE, Gilson AM. To what extent has the WHO Ladder influenced morphine consumption in the world? A conceptual framework, review of consumption data, recommendations and resources. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Prepared for the Serturner Workshop; Einbeck, Germany; August 1997 (Monograph).
  32. Sohn W, Zenz M. Morphinverschreibung in Europa. Berlin, Germany: Springer-Verlag; 1998.
  33. Larue F, Fontaine A, Colleau SM. Underestimation and undertreatment of pain in HIV disease: a multicentre study. Br Med J. 1997;314:23-28.
  34. Blengini C. Il consumo di morfina in Europa. S.I.M.G.: Rivista di Politica Professionale della Medicina Generale. 1998;8:13-16.
  35. Pain & Policy Studies Group. Availability of opioid analgesics for cancer pain relief. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Prepared for the 8th Annual Palliative Medicine Advanced Course; Puszczykowo, Poland; 24-29 May 1998 (Monograph).
  36. Colleau SM. Education in cancer pain control and palliative care: a guide to resources. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Prepared for the 8th Annual Advanced Palliative Medicine Course; Puszczykowo, Poland; 24-29 May 1998 (Monograph).
  37. Anon. The Poznan Declaration. Eur J Palliat Care. 1999;6:61-63
  38. Joranson DE. Availability of opioid analgesics in Asia: progress, problems, recommendations. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Presented at the 14th Study Programme for Overseas Experts on Drug Abuse and Narcotics Control; Tokyo, Japan; 22 June-16 July 1999 (Monograph).
  39. Joranson DE, Gilson AM, Nelson JM. Opioid availability in Asia. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Presented at the 14th Study Programme for Overseas Experts on Drug Abuse and Narcotics Control; Tokyo, Japan; 28 June 1999 (Monograph).
  40. Joranson DE, Smokowski PR. Selected trends in opioid consumption for medical purposes. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Presented at the 11th Study Programme for Overseas Experts on Drug Abuse and Narcotics Control; Tokyo, Japan; 19 June-17 July 1996 (Monograph).
  41. Joranson DE. Opioid Availability in Africa. J Pharm Care Pain Symptom Control. 1998;6:1-4.
  42. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA. 2000; 283:1710-1714.
  43. Joranson DE, Gilson AM, Dahl JL, Haddox JD. Pain management, controlled substances and state medical boards: a decade of change. JAMA, in review.
  44. Gilson AM, Joranson DE. Controlled substances and pain management: knowledge and attitudes of state medical regulators. J Pain Symptom Manage, in press.
  45. Federation of State Medical Boards of the United States Inc. Model guidelines for the use of controlled substances for the treatment of pain. Euless, Tex: Federation of State Medical Boards of the United States Inc; 1998.
  46. Colleau SM, Weis N, Thomas E. WHO guidelines on cancer pain, opioid availability, symptom control and palliative care: ordering information. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Poster presented at the 9th World Congress on Pain, International Association for the Study of Pain; Vienna, Austria; 19-26 August 1999.
  47. Joranson DE. Availability of opioid analgesics for cancer pain relief. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Presented at the WHO Regional Workshop and Saitama-Western Pacific Workshop; Saitama, Japan; March 1998 (Monograph).
  48. World Health Organization Western Pacific Regional Office. Workshop on strengthening health professional education in cancer pain relief and development of palliative care expertise. Saitama, Japan; 23-26 March 1998. Report Series No. RS/98/GE/02 (JPN). Manila, Philippines: World Health Organization; September 1998.
  49. Joranson, DE. Ensuring availability of opioid analgesics to the patient. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Presented at the 2nd National Conference on Palliative Care; Penang, Malaysia; 24-28 March 1999.
  50. Joranson, DE. Opioids for chronic pain: myths and facts. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Presented at the 2nd National Conference on Palliative Care; Penang, Malaysia; 24-28 March 1999.
  51. World Health Organization Western Pacific Regional Office. Mission report: review of drug availability for cancer pain relief in Malaysia. World Health Organization Regional Office for the Western Pacific; 28 October 1999.
  52. Indian Association of Palliative Care. Improving availability of opioids in India: preliminary proposal to Ministry of Health, New Delhi. Madison, Wisconsin; Calicut, India: University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care, Indian Association of Palliative Care and the WHO Demonstration Project at Pain and Palliative Care Society; 1999.
  53. World Health Organization Collaborating Centre for Palliative Cancer Care. Looking forward to cancer pain relief for all: international consensus on the management of cancer pain. Oxford, UK: World Health Organization Collaborating Centre for Palliative Cancer Care; 1997.
  54. Joranson DE. Drug regulation, drug dependence and morphine in cancer pain management. University of Wisconsin Pain & Policy Studies Group/WHO Collaborating Center for Policy and Communication in Cancer Care. Presented at the Saitama-Western Pacific Workshop on Cancer Pain Relief and Palliative Care; Saitama, Japan; March 1998.
  55. International Narcotics Control Board. Report of the International Narcotics Control Board for 1999. Vienna, Austria: International Narcotics Control Board; 2000.



    PPSG Home     Table of Contents    Top   Table 1